{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:10:00Z","timestamp":1760235000522,"version":"build-2065373602"},"reference-count":15,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Melanoma represents the most malignant type of skin cancer, with increasing incidence worldwide [...]<\/jats:p>","DOI":"10.3390\/ijms22147723","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T05:10:59Z","timestamp":1626757859000},"page":"7723","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Special Issue \u201cPrecision Oncology in Melanoma Progression\u201d"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-4454","authenticated-orcid":false,"given":"Simona","family":"D\u2019Aguanno","sequence":"first","affiliation":[{"name":"Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13046-021-01926-6","article-title":"Hypoxia-dependent drivers of melanoma progression","volume":"40","author":"Mallone","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jid.2020.03.943","article-title":"Treatment of Advanced Melanoma in 2020 and Beyond","volume":"141","author":"Jenkins","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.21873\/anticanres.10986","article-title":"Lymphangiogenesis and Anti-lymphangiogenesis in Cutaneous Melanoma","volume":"36","author":"Raica","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1200\/JCO.20.00198","article-title":"Systemic Therapy for Melanoma: ASCO Guideline","volume":"38","author":"Seth","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ottaviano, M., Giunta, E.F., Tortora, M., Curvietto, M., Attademo, L., Bosso, D., Cardalesi, C., Rosanova, M., Placido, P.D., and Pietroluongo, E. (2021). BRAF Gene and Melanoma: Back to the Future. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073474"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nm.3984","article-title":"Pan-cancer analysis of the extent and consequences of intratumor heterogeneity","volume":"22","author":"Andor","year":"2016","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Shaw","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Grzywa, T.M., Koppolu, A.A., Paskal, W., Klicka, K., Rydzanicz, M., Wejman, J., P\u0142oski, R., and W\u0142odarski, P.K. (2021). Higher Mutation Burden in High Proliferation Compartments of Heterogeneous Melanoma Tumors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083886"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chacon, A.C., Melucci, A.D., Qin, S.S., and Prieto, P.A. (2021). Thinking Small: Small Molecules as Potential Synergistic Adjuncts to Checkpoint Inhibition in Melanoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063228"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kim, N., Shin, I., Lee, J., Jeon, E., Kim, Y., Ryu, S., Ju, E., Cho, W., and Sim, T. (2021). Novel and Potent Small Molecules against Melanoma Harboring BRAF Class I\/II\/III Mutants for Overcoming Drug Resistance. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073783"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Valenti, F., Falcone, I., Ungania, S., Desiderio, F., Giacomini, P., Bazzichetto, C., Conciatori, F., Gallo, E., Cognetti, F., and Ciliberto, G. (2021). Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083837"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Tonella, L., Pala, V., Ponti, R., Rubatto, M., Gallo, G., Mastorino, L., Avallone, G., Merli, M., Agostini, A., and Fava, P. (2021). Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094561"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mazurkiewicz, J., Simiczyjew, A., Dratkiewicz, E., Zi\u0119tek, M., Matkowski, R., and Nowak, D. (2021). Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020529"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Papaccio, F., Kovacs, D., Bellei, B., Caputo, S., Migliano, E., Cota, C., and Picardo, M. (2021). Profiling Cancer-Associated Fibroblasts in Melanoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147255"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Pawlikowska, M., J\u0119drzejewski, T., Slominski, A.T., Bro\u017cyna, A.A., and Wrotek, S. (2021). Pigmentation Levels Affect Melanoma Responses to Coriolus versicolor Extract and Play a Crucial Role in Melanoma-Mononuclear Cell Crosstalk. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115735"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7723\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:32:03Z","timestamp":1760164323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":15,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22147723"],"URL":"https:\/\/doi.org\/10.3390\/ijms22147723","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2021,7,20]]}}}